Fig. 1From: TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancersTOP2A expression detected at IHC (images acquired by optical microscope 20×). a, b TOP2A over-expression above cut-off of 18% nuclear cells signature versus. c, d TOP2A expression below cut-offBack to article page